Fisher & Paykel Healthcare's revenue for the
six
months ended in Sep. 2024 was €529 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €1,057 Mil.
Fisher & Paykel Healthcare's Revenue per Share for the
six
months ended in Sep. 2024 was €0.90.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €1.79.
Warning Sign:
Fisher & Paykel Healthcare Corp Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Fisher & Paykel Healthcare was 9.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -3.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 12.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Fisher & Paykel Healthcare's highest 3-Year average Revenue per Share Growth Rate was 26.20% per year. The lowest was -3.70% per year. And the median was 10.30% per year.
Fisher & Paykel Healthcare Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fisher & Paykel Healthcare's Revenue
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Revenue distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Revenue falls into.
Fisher & Paykel Healthcare Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,057 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Fisher & Paykel Healthcare Revenue Related Terms
Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:FPLB has been successfully added to your 